Peripheral Demyelinating Diseases: From Biology to Translational Medicine
Open Access
- 19 March 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 10, 87
- https://doi.org/10.3389/fneur.2019.00087
Abstract
Demyelinating diseases represent a spectrum of disorders that impose significant burden on global economy and society. Generally, the prognosis of these diseases is poor and there is no available cure. In recent decades, research has shed some light on the biology and physiology of Schwann cells and its neuroprotective effects in the peripheral nervous system (PNS). Insults to the PNS by various infectious agents, genetic predisposition and immune-related mechanisms jeopardize Schwann cell functions and cause demyelination. To date, there are no effective and reliable biomarkers for PNS-related diseases. Here, we aim to review the following: pathogenesis of various types of peripheral demyelinating diseases such as Guillain-Barre syndrome, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Anti-Myelin Associated Glycoprotein Neuropathy, POEMS syndrome, and Charcot-Marie-Tooth disease; emerging novel biomarkers for peripheral demyelinating diseases, and Schwann cell associated markers for demyelination.Funding Information
- Universiti Kebangsaan Malaysia
This publication has 103 references indexed in Scilit:
- Guillain-Barré Syndrome: Natural history and prognostic factors: a retrospective review of 106 casesBMC Neurology, 2013
- Charcot‐marie‐tooth disease subtypes and genetic testing strategiesAnnals of Neurology, 2011
- Update on Charcot-Marie-Tooth DiseaseCurrent Neurology and Neuroscience Reports, 2010
- Incidence and prevalence of CIDP and the association of diabetes mellitusNeurology, 2009
- Mitofusin 2 tethers endoplasmic reticulum to mitochondriaNature, 2008
- Development of the Schwann cell lineage: From the neural crest to the myelinated nerveGlia, 2008
- Ablation of the UPR-Mediator CHOP Restores Motor Function and Reduces Demyelination in Charcot-Marie-Tooth 1B MiceNeuron, 2008
- Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathyJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Demyelinating diseasesJournal of Clinical Pathology, 2006
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001